BulletYear 2011 - 2012
BulletYear 2010 - 2011
BulletYear 2009 - 2010
BulletYear 2008 - 2009



BulletPapers

Drug formulary

Year 2011 - 2012

LC Paper No.PaperMeeting date
CB(2)258/11-12(07) Administration's paper on financial assistance to needy patients to meet expenses on privately purchased drugs 14 November 2011
CB(2)1680/11-12(01) Administration's response on financial assistance to needy patients to meet expenses on privately purchased drugs (Follow-up paper) 14 November 2011
CB(2)258/11-12(08) Paper on financial assistance to needy patients to meet expenses on privately purchased drugs prepared by the Legislative Council Secretariat (background brief) 14 November 2011
CB(2)1794/11-12(01) Chronic Obstructive Pulmonary Disease Concern Group's letter dated 18 April 2012 to the Financial Secretary on funding to the Hospital Authority to expand the clinical application of long-acting bronchodilators for the treatment for chronic obstructive pulmonary disease (Chinese version only) 14 May 2012
CB(2)2526/11-12(01) Administration's paper on regularization of Community Care Fund Medical Assistance Programme Second Phase 10 July 2012
CB(2)2526/11-12(02) Paper on regularization of Community Care Fund Medical Assistance Programme Second Phase prepared by the Legislative Council Secretariat (Background brief) 10 July 2012


Year 2010 - 2011

LC Paper No.PaperMeeting date
CB(2)362/10-11(01) Administration's response on proposal to discuss incorporation of oral chemotherapy drugs into the Drug Formulary as subsidised drugs 8 November 2010
14 February 2011
CB(2)362/10-11(02) Administration's supplementary information on proposal to discuss incorporation of oral chemotherapy drugs into the Drug Formulary as subsidised drugs 8 November 2010
14 February 2011
CB(2)376/10-11(01) Hon Alan LEONG's letter on proposal to discuss incorporation of oral chemotherapy drugs into the Drug Formulary as subsidised drugs dated 5 November 2010 (Chinese version only) 8 November 2010
14 February 2011
CB(2)973/10-11(05) Administration's paper on update on the Drug Formulary of the Hospital Authority 14 February 2011
14 June 2011
CB(2)1602/10-11(01) Administration's response on Drug Formulary of the Hospital Authority (Follow-up paper) 14 February 2011
14 June 2011
CB(2)1142/10-11(01) Letter dated 18 February 2011 from The Thalassaemia Association of Hong Kong to the Political Assistant to Secretary for Food and Health expressing views on the iron chelating therapy for Thalassaemia patients (Chinese version only) 14 February 2011
CB(2)973/10-11(06) Paper on update on the Drug Formulary of the Hospital Authority prepared by the Legislative Council Secretariat (background brief) 14 February 2011
CB(2)1001/10-11(04) Submission on update on the Drug Formulary of the Hospital Authority from a deputation (梨木樹社區關注組) (Chinese version only) 14 February 2011
CB(2)1001/10-11(05) Submission on update on the Drug Formulary of the Hospital Authority from an organization (一群港島區長期病患長者) (Chinese version only) 14 February 2011
CB(2)1001/10-11(03) Submission on update on the Drug Formulary of the Hospital Authority from Oral Chemotherapy Advocacy Group (Chinese version only) 14 February 2011
CB(2)1001/10-11(02) Submission on update on the Drug Formulary of the Hospital Authority from The Thalassaemia Association of Hong Kong (Chinese version only) 14 February 2011
FS32/11-12 Paper on Drug Formulary of the Hospital Authority prepared by the Legislative Council Secretariat(Fact sheet) (Follow-up paper) 14 June 2011
CB(2)2003/10-11(01) Paper on Drug Formulary of the Hospital Authority prepared by the Legislative Council Secretariat (updated background brief) 14 June 2011
CB(2)2055/10-11(03) Submission on Drug Formulary of the Hospital Authority from Alliance for Patients' Mutual Help Organizations (Chinese version only) 14 June 2011
CB(2)2089/10-11(02) Submission on Drug Formulary of the Hospital Authority from Civic Party (Chinese version only) 14 June 2011
CB(2)2055/10-11(02) Submission on Drug Formulary of the Hospital Authority from Consumer Council (Chinese version only) 14 June 2011
CB(2)2123/10-11(01) Submission on Drug Formulary of the Hospital Authority from Democratic Party of Hong Kong (Chinese version only) 14 June 2011
CB(2)2055/10-11(01) Submission on Drug Formulary of the Hospital Authority from Hong Kong Adult Blood Cancer Group Ltd. (English version only) 14 June 2011
CB(2)2003/10-11(02) Submission on Drug Formulary of the Hospital Authority from Hong Kong Neuro-Muscular Disease Association (Chinese version only) 14 June 2011
CB(2)2003/10-11(06) Submission on Drug Formulary of the Hospital Authority from Mr YEUNG Wai-sing, Eastern District Council Member (Chinese version only) 14 June 2011
CB(2)2003/10-11(07) Submission on Drug Formulary of the Hospital Authority from Oral Chemotherapy Advocacy Group 14 June 2011
CB(2)2055/10-11(04) Submission on Drug Formulary of the Hospital Authority from Retina Hong Kong (Chinese version only) 14 June 2011
CB(2)2003/10-11(04) Submission on Drug Formulary of the Hospital Authority from The Brightening Association (HK) Ltd. (Chinese version only) 14 June 2011
CB(2)2089/10-11(01) Submission on Drug Formulary of the Hospital Authority from The Hong Kong Association of the Pharmaceutical Industry (Chinese version only) 14 June 2011
CB(2)2003/10-11(03) Submission on Drug Formulary of the Hospital Authority from The Hong Kong Medical Association 14 June 2011
CB(2)2026/10-11(01) Submission on Drug Formulary of the Hospital Authority from The Pharmaceutical Society of Hong Kong (English version only) 14 June 2011
CB(2)2003/10-11(05) Submission on Drug Formulary of the Hospital Authority from The Thalassaemia Association of Hong Kong (Chinese version only) 14 June 2011
CB(2)2368/10-11(01) Letter from Hind Wing Co., Ltd. dated 7 July 2011 expressing views on two iron chelating agents for thalassemia patients in public hospitals, i.e. Deferiprone and Deferasirox (English version only) 13 July 2011*


Year 2009 - 2010

LC Paper No.PaperMeeting date
CB(2)2361/09-10(01) Letter dated 5 October 2010 from The Thalassaemia Association of Hong Kong to the Chief Manager (Cluster Performance) of the Hospital Authority regarding iron chelating agents for Thalassemia patients in public hospitals (Chinese version only) 30 September 2010*


Year 2008 - 2009

LC Paper No.PaperMeeting date
CB(2)1740/08-09(04) Administration's paper on updates on the Drug Formulary of the Hospital Authority 8 June 2009
CB(2)2484/08-09(01) Administration's response on updates on the Drug Formulary of the Hospital Authority 8 June 2009
CB(2)1740/08-09(05) Paper on updates on the Drug Formulary of the Hospital Authority prepared by the Legislative Council Secretariat (background brief) 8 June 2009
CB(2)1802/08-09(01) Submission on updates on the Drug Formulary of the Hospital Authority from The Thalassaemia Association of Hong Kong (English Version Only) 8 June 2009
CB(2)1934/08-09(01) Administration's paper on policy on use of drugs in life threatening emergency situations 19 June 2009
CB(2)206/09-10(01) Administration's response on policy on use of drugs in life threatening emergency situations 19 June 2009

* Issue date